Back to Search

PHILIP MOSCA, MD

MD

Specialist

NPI: 1598768715Individual

Specialties, Licenses & Credentials

SpecialistPrimary

Specialist

Code: 174400000X

11232(OK)

Research & Publications (20)

Targeting Akt3 signaling in malignant melanoma using isoselenocyanates.
PMID 19208796·Clin Cancer Res·2009
4-observational
Can surgeons improve survival in stage IV melanoma?
PMID 18270974·J Surg Oncol·2008
6-review
Dendritic cell vaccines.
PMID 17485358·Front Biosci·2007
6-review
Current immunotherapeutic strategies in malignant melanoma.
PMID 18022553·Surg Oncol Clin N Am·2007
6-review
Quality in emergency departments: a study on 3,285,440 admissions.
PMID 17506233·J Prev Med Hyg·2007
4-observational
Immune monitoring.
PMID 16211879·Cancer Treat Res·2005
6-review
Melanoma arising in a skin graft.
PMID 15613891·Ann Plast Surg·2005
5-case
Immunotherapy of surgical malignancies.
PMID 14749625·Curr Probl Surg·2004
6-review
Proteomics for monitoring immune responses to cancer vaccines.
PMID 12669469·Curr Opin Mol Ther·2003
6-review
Immunoregulatory T cells in cancer immunotherapy.
PMID 12517262·Expert Opin Biol Ther·2002
6-review

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
4200 S. DOUGLAS AVE., STE. 300
OKLAHOMA CITY, OK 73109

Quick Facts

NPI
1598768715
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile